Immunotherapy

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Participate in a Study

A critical part of our mission at Seattle Cancer Care Alliance (SCCA) is to bring promising new treatments to patients faster. Patients who participate in clinical studies often have the first chance to benefit from treatment approaches that have shown promise in earlier research.

In the case of novel immune-based therapies, SCCA patients frequently have more treatment options than they might find elsewhere, including the chance to participate in one of the many ongoing clinical studies conducted at SCCA and its founding organizations, Fred Hutchinson Cancer Research Center, Seattle Children’s, and UW Medicine. Participants in these studies make an important contribution to medical science by helping doctors learn more about their disease and the treatment under investigation.

Our internationally renowned researchers are breaking new ground in enlisting the immune system in fighting a range of cancers—while avoiding the toxic side effects associated with many cancer treatments. Although clinical studies may pose some risks, SCCA clinicians take careful steps to protect the people who participate.

For more information about our clinical studies, please see our Patient Guide to Clinical Studies. We also urge you to discuss potential studies with your medical oncologist and treatment team.